analyst thomas mccrann merrill lynch said reiterated buy recommendation wang laboratories inc noting successful cost cutting campaign could reduce earnings loss expected for third quarter ending march wang was most actively traded stock american stock exchange rising mccrann said wang little bit ahead were expected cost reductions and odds have increased loss for quarter will less had been expected mccrann said expects wang report break even earnings per share only small loss per share for third quarter said for year however company should report loss about cts share compared with earnings about cts share year ago reuter 